Clinical Trial: A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Obesity
Study Type: INTERVENTIONAL
Official Title: Comparing the Pharmacokinetics of Cagrilintide and Semaglutide Following Single Subcutaneous Doses of Different CagriSema Presentations, in a Crossover Manner in Adult Participants With Overweight or
Brief Summary:
This study will compare the blood levels of cagrilintide and semaglutide when the same dose is given in two different versions of CagriSema.CagriSema is a medicine that combines two medicines called cagrilintide and semaglutide.It is still being tested in studies and is not yet available for doctors to prescribe.Participants will get an injection with each of the two versions of CagriSema at two different times at the clinic.Like all medicines, the study medicine may have side effects.The study will last for about…
Read more